This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

PDF
Markdown

2021-06-30-accounts

		Page
Trustees' report		1-3
Independent examiner's report
Statement offinancial activities		5-6
Summary income and expenditure	account
Balance sheet
Notes to the financial statements		9-18

Dr Gareth Payne
Dr Jeremy Bland
Dr James Burge	(Resigned	13November	2020)
Dr Shereef Mytheen	(Resigned	13November	2020)
Dr Ming Lai
DrAdrian Fowle	(Resigned	13November	2020)
Dr Ronit Pressler
Dr Veronica Leach
DrArup Mallik	(Resigned	13November	2020)
Dr Rachel Thornton	(Resigned	13November	2020)
Professor M Koltzenburg
Ms Lesley Chandra
DrAndrew Michell
Dr Mark Baker
Dr Daniel Konn
Dr Sushma Goyal
Dr Stephan Jaiser	(Appointed	13November	2020)
Dr Nandini Mullatti	(Appointed	13November	2020)
Dr Elisaveta Sokolov	(Appointed	13November	2020)
Dr Jacquie Deeb	(Appointed	13November	2020)

			N 0		O O	W		CIL Ol O	IA	CD CD	IA IA			CI
								CD	IA		40
			C		O CLI	W
			E		CI CLI
			00C
			IU
			0 0 0	N 13C	O CC CI CC	W				CD			Cl Cl Cl IA
			Ib
			ID
			Cl 0	ID '0 C	O CLIO CLI	Cll		CDO Ol	IA IA	LA CC			CD CO CO Cl			OE
			Cl
			Cl
			IC0		CLI CI	W		Ol	O 'll
					CLI			4C	CC	CD
			00	N U	~ CCO	Ill								IO		CC CII CO
			E	4	CC
Q0 0 0)			0 'U C lU 'U 4l0 N4l	N '0 L 4	t- O III	W		O IA IO	'	CD CO CD			CI CI IA
Z
IL0 ILD			'U Cl0 Cl	N '0 C	~ Ol O Ol	W		Ol	O 0	IO CLI	CO CI CO		Ol IA CI			CC Ill CI OO
			Cl
LLIX			CD
						N
O						CI0Z								CI
X	tlat
	LU
0		0
0	I 0	LU 5													ID I0 4 ID
I- LLI O0 loz M E IL tQ LLIzI-	0z LL IL I z K LU LU I- N	0 g LLI I 0 U.					0 CI E00C	'U N Vl 0 ICC0 CI	ID ID 0 IC 0 m 'C IC	N C Cl E N Cl 'C	0 E00C IC0	C0 CI '0 4I CC IU	Vl N 0 IC Cl J2 IC IC0	N C0E N CI C0 N CI ID N0 NC ClUl YlZ	N ID I0 0 Cl0 Ul00 Ul 0 Ul C 0 Cl Z	4l ClC N +~

		O	Ol
		CI
E		O CI	CII					CI CI CI Cl	ooo Cl
0 'O
C
UJ
'O 0	ID '0L	O CI! Cl	Cll					CO Cl Cl	IO CI CI
		CI!						CII	Ctt
tD0
'0 ID 0	tD 'O C	O CI	IIC		oE				Ctt CO
									ttt
N
ID
Dl		c- OCo	CII		CO		CO ttt		Cl Cl
		OC			CO		CO
					Ctt		Ctt		Ol
N E	N 'O L	c CV O CV	Itl		Ctt Ctt IO	IO		CI CI CI	ooo
0OL
IU
'0 Dl0	N '0c	c- o CC	CIC					CO CI CI		ID 4l
I										4l
N
Dl
I4"
										O
'0 N0	N '0 c	c 0! o0!	Itl		CI! Ill CI CD	CV CI! IO	IO			ID N Ol00
Dl										ID
N
LD										ID ID N
			N Dl 0Z							ID0 C ID IDC	tDS 04!
										ID Ol	Ol C
				ID I0 ID						4! Ih0 O	C C 00
				N						0C	E0
				ID I0						ID ID	4 4l
				0 Dl0 Ol C0 Ol 0 Ol C O 4l Z	4l NC N JD	ID 13 4 ID fl ID ID 4 ID ID N ID0 G	N 'O C C 4l 4l 0 E 4lZ	CI Ctt CI Ctt ID N N0 ID ID J2 'O C IL	Ol CI Ol 4lC l CI ID N4l0C ID ID 'O C IL	0 ID 4!0C IDC IC 40 Cl E 4l N 4l I-	ID 4l IDO. IC0 ID0 E 8C

			All income funds
			2021 F	2020f
Gross income			39,819	28,552
Gains/(losses) on	investments		6,037	(7,579)
Transfer from/(to)	endowment	funds	3,622	(4,438)
Total income in the reporting		period	49,478	16,535
Total expenditure	from income funds		21,091	25,869
Net income/(expenditure) for the year			28,387	(9,334)

				2021		2020
			Notes	6		6
Fixed assets
Investments					91,858		82,199
Current assets
Debtors			12	60,284		60,783
Cash at bank and	in	hand		53,516		32,209
				113,800		92,992
Creditors: amounts		falling due within
one year			13	(11,638)		(9,558)
Net current assets					102,162		83,434
Total assets less	current liabilities				194,020		165,633
Capital funds
Endowment funds	-	Dr Last Memorial
Fund					10,000		10,000
Income funds
MSC Fund				12,006		12,006
Dr Last Memorial	Fund			963
Christine and Adrian		Fowle Prize Fund		5,750
			15		18,719		12,006
Unrestricted funds					165,301		143,627
					194,020		165,633

		Unrestricted	Restricted	Total	Total
		funds	funds
		2021	2021	2021	2020
		6	F	6	F
Donations	and gifts				4,239
Membership	fees	17,941		17,941	14,853
Other			6,250	6,250
		17,941	6,250	24,191	19,092
Forthe year ended 30June 2020		19,092			19,092

				2021	2020
				6
Delegate	fee		income	5,001	3,940
Exhibitor	fee		income	7,400	1,601
				12,401	5,541
A~li	1	t	d
Unrestricted			funds	12,401
Forthe	year		ended 30June 2020
Unrestricted			funds		5,541
					5,541

	Unrestricted	Restricted	Total	Total
	funds	funds	2021	2020
Income From Listed Investments	2,207	963	3,170	3,771
Bank Interest	57		57	148
	2,264		3,227	3,919
Forthe year ended 30June 2020	2,725	1,194		3,919

5	Charitable activities	Charitable activities
				Scientific	Triennial	Grants	Total	Total
				Meetings			2021	2020
				6			6	E
	Meeting costs							7,208
	ACNS meeting	costs						3,114
	Other meeting	costs		(127)			(127)	182
				(127)			(127)	10,504
	Grant funding	ofactivities (see note 6)
						1,612	1,612	9,425
	Share ofsupport costs (see note 7)			9,995		6,263	16,258	2,559
	Share ofgovernance		costs (see note
	7)			3,348			3,348	3,381
				13,216		7,875	21,091	25,869
	A~li 1 r	d
	Unrestricted funds			13,216		7,375	20,591
	Restricted funds					500	500
				13,216		7,875	21,091
	Forthe year ended		30June 2020
	Meeting costs			5,228	1,980			7,208
	ATCN costs
	ACNS meeting	costs		3,114				3,114
	Other meeting	costs		182				182
				8,524	1,980			10,504
	Grant funding	ofactivities (see note 6)
						9,425		9,425
	Share ofsupport costs (see note 7)			2,559				2,559
	Share ofgovernance		costs (see note
	7)			3,381				3,381
				14,464	1,980	9,425		25,869
	A~li b t	d
	Unrestricted funds			14,464	1,980	4,425		20,869
	Restricted funds					5,000		5,000
				14,464	1,980	9,425		25,869

			2021	2020
			6
Grants	to	organisations		500
Grants	to	individuals	1,612	8,925
			1,612	9,425

Support cos	ts
		Support Governance		2021	2020
		costs	costs
		E	6
Website		1,863		1,863	990
Clerical Assistance		12,527		12,527
Subscription	- IFCN	498		498	964
Subscription	- JNC	250		250	250
Subscription	-AANEM	976		976
Bank charges		201		201	355
Sundry expenses		(57)		(57)
Examination	fees		2,653	2,653	2,656
Accountancy			240	240	240
Legal and professional			455	455	485
		16,258	3,348	19,606	5,940
Analysed between
Charitable activities		16,258	3,348	19,606	5,940

							2021	2020
							Number	Number
Total
Net gains/(losses)		on investments
			Unrestricted	Endowment	Total	Unrestricted	Endowment	Total
			funds	funds		funds	funds
				general			general
				2021f		2020 f	2020 f	2020 F
Revaluation of
investments			6,037	3,622	9,659	(7,579)	(4,438)	(12,017)
Fixed asset investments
						Listed	Unlisted	Total
					investments investments
						f	f
Cost or	valuation
At 1 July	2020 &30	June	2021			72,199	10,000	82,199
Carrying	amount
At 30June 2021						72,199	10,000	82,199
At 30June 2020						72,199	10,000	82,199

13	Creditors: amounts	falling	due within one year
					2021	2020
				Notes	6	8
	Deferred income			14	8,512	6,932
	Accruals				3,126	2,626
					11,638	9,558
14	Deferred income
					2021f	2020 8
	Deferred scientific meeting		delegate fees		8,512	6,932

16	Analysis of	net assets between funds
			Unrestricted	Restricted	Endowment	Total
			Fund	Funds	Fund
			6	F		6
	Fund balances at 30June 2021 are
	represented	by:
	Investments		81,858		10,000	91,858
	Current assets/(liabilities)		83,443	18,719		102,162
			165,301	18,719	10,000	194,020
	Fund balances at 30June 2020 were
	represented	by:
	Investments		72,199		10,000	82,199
	Current assets/(liabilities)		71,428	12,006		83,434
			143,627	12,006	10,000	165,633